Red Light Therapy for Glaucoma: Science, Safety, and What the Research Shows outlines how photobiomodulation supports retinal ganglion cell health in glaucoma — neuroprotection mechanisms, peer-reviewed evidence, safety, and compatibility with prescribed care.
Red Light Therapy for Eyes at Home: A Guide to Safety and Vision Support examines the science behind ocular photobiomodulation, details necessary safety and device selection criteria, outlines evidence-based clinical benefits for various eye conditions, and provides practical protocols for consistent, effective home use.
Red light (630-670 nm) counteracted blue light toxicity in retinal ganglion cells through enhanced ATP, increased antioxidants, and mitochondrial protection.
Red and near-infrared wavelengths (650–800 nm) were shown to activate cytochrome c oxidase (Complex IV), increase ATP production, and promote mitochondrial resilience. In ischemic RGC models, additional long-wavelength light exposure preserved mitochondrial function and improved cellular survival.
